BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27550202)

  • 1. The Role of Autophagy in Rheumatic Disease.
    Feng Y; Li B; Li XY; Wu ZB
    Curr Drug Targets; 2018; 19(9):1009-1017. PubMed ID: 27550202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy: controlling cell fate in rheumatic diseases.
    Rockel JS; Kapoor M
    Nat Rev Rheumatol; 2016 Sep; 12(9):517-31. PubMed ID: 27334205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets in rheumatic diseases: friend or foe?
    Gasparyan AY; Ayvazyan L; Pretorius E; Kitas GD
    Curr Pharm Des; 2014; 20(4):552-66. PubMed ID: 23565634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy in Rheumatic Diseases: Role in the Pathogenesis and Therapeutic Approaches.
    Celia AI; Colafrancesco S; Barbati C; Alessandri C; Conti F
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rheumatic diseases in pregnancy].
    Märker-Hermann E; Bauer H; Gromnica-Ihle E
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction in rheumatic autoimmune diseases.
    Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
    Atherosclerosis; 2012 Oct; 224(2):309-17. PubMed ID: 22673743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus.
    Pierdominici M; Vomero M; Barbati C; Colasanti T; Maselli A; Vacirca D; Giovannetti A; Malorni W; Ortona E
    FASEB J; 2012 Apr; 26(4):1400-12. PubMed ID: 22247332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of autophagy in the pathogenesis of systemic lupus erythematosus.
    Liu X; Qin H; Xu J
    Int Immunopharmacol; 2016 Nov; 40():351-361. PubMed ID: 27673477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.
    Cronstein BN; Sitkovsky M
    Nat Rev Rheumatol; 2017 Jan; 13(1):41-51. PubMed ID: 27829671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
    Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
    Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement in the immunopathogenesis of rheumatic disease.
    Sturfelt G; Truedsson L
    Nat Rev Rheumatol; 2012 Aug; 8(8):458-68. PubMed ID: 22664835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 as a therapeutic target for rheumatic diseases.
    Ferrándiz ML; Nacher-Juan J; Alcaraz MJ
    Biochem Pharmacol; 2018 Jun; 152():338-346. PubMed ID: 29660314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological management of inflammatory rheumatic conditions].
    Bannwarth B
    Therapie; 2011; 66(5):377-81. PubMed ID: 22031680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB and rheumatic diseases.
    Okamoto T
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):359-72. PubMed ID: 17214582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy in autoimmune disease.
    Yang Z; Goronzy JJ; Weyand CM
    J Mol Med (Berl); 2015 Jul; 93(7):707-17. PubMed ID: 26054920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trained immunity and inflammation in rheumatic diseases.
    Badii M; Gaal O; Popp RA; Crișan TO; Joosten LAB
    Joint Bone Spine; 2022 Jul; 89(4):105364. PubMed ID: 35219890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy and immunological aberrations in systemic lupus erythematosus.
    Qi YY; Zhou XJ; Zhang H
    Eur J Immunol; 2019 Apr; 49(4):523-533. PubMed ID: 30776086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current perspective on rituximab in rheumatic diseases.
    Schioppo T; Ingegnoli F
    Drug Des Devel Ther; 2017; 11():2891-2904. PubMed ID: 29042750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?
    Kato M; Yasuda S; Atsumi T
    Rheumatol Int; 2018 Aug; 38(8):1333-1338. PubMed ID: 29623390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines in rheumatic diseases.
    Szekanecz Z; Szücs G; Szántó S; Koch AE
    Curr Drug Targets; 2006 Jan; 7(1):91-102. PubMed ID: 16454702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.